The San Francisco-based company, founded in 2010, uses computational immunology, bioengineering, and robotics to develop breakthrough technologies that can drug previously challenging targets. Distributed Bio offers a suite of antibody discovery tools to support life sciences research and drug discovery, including analysis and engineering of antibodies, TCRs, and peptides, advanced antibody libraries, and readily formattable antibody fragments. The company's tools have enabled healthcare professionals to recover high affinity, drug-worthy antibodies against any target, supporting thousands of high affinity developable antibodies against any drug target of interest.